FITC anti-pig CD4a
CD4 is a 55 kDa, type I glycoprotein expressed by tymocytes, helper T cells (Th), plasmacytoid dendritic cells (also known as natural interferon-producing cells or NIPC). In Pigs there a CD4+/CD8+ double positive subset that increase with age and have characteristics of memory T cells.
PRODUCT DETAILS
Clone: 74-12-4
Antibody Type: Monoclonal
Reactivity: Pig
Format: FITC
Host: Mouse
Isotype: IgG2b, κ
Applications: FC - Quality tested
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
CD4 is a 55 kDa, type I glycoprotein expressed by tymocytes, helper T cells (Th), plasmacytoid dendritic cells (also known as natural interferon-producing cells or NIPC). In Pigs there a CD4+/CD8+ double positive subset that increase with age and have characteristics of memory T cells.
PRODUCT DETAILS
Clone: 74-12-4
Antibody Type: Monoclonal
Reactivity: Pig
Format: FITC
Host: Mouse
Isotype: IgG2b, κ
Applications: FC - Quality tested
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
Description
CD4 is a 55 kDa, type I glycoprotein expressed by tymocytes, helper T cells (Th), plasmacytoid dendritic cells (also known as natural interferon-producing cells or NIPC). In Pigs there a CD4+/CD8+ double positive subset that increase with age and have characteristics of memory T cells.
PRODUCT DETAILS
Clone: 74-12-4
Antibody Type: Monoclonal
Reactivity: Pig
Format: FITC
Host: Mouse
Isotype: IgG2b, κ
Applications: FC - Quality tested
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
